We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint Venture

16 Jan 2007 07:01

Amphion Innovations PLC16 January 2007 Amphion Innovations, plc Creation of a Gulf-based Joint Venture 16 January 2007, London, UK - Amphion Innovations plc ("Amphion"), a builder ofcompanies in life sciences and technology, today announces that it has signed aHeads of Agreement with a Gulf-based investment company, MS Holdings, backed bythe Al-Sayer and Al-Mutawa families of Kuwait, to create a Gulf-based jointventure, MSA Investors ("MSA"). The Gulf Cooperation Council countries of the Arabian Gulf now represent thefastest growing economy after China and India. Building on Amphion'scompany-building strategy and its long-standing ties to the region, the jointventure's objective will be to create new markets and strategic partnerships forAmphion's Partner Companies, identify new investment opportunities in the regionin areas of particular Amphion expertise and provide strong access to capitaland opportunities from both existing and new Gulf investors. Under the Heads of Agreement, Amphion commits to the formation and incorporationof MSA and to the establishment and operation of two additional companies to bemanaged by MSA, Saydanah and Suvani. Amphion's Gulf partners have committedUS$1 million to the creation of these companies and additional investment upontheir completion. Saydanah is being established by our partners in the region in order to bring "functional foods" to a sizeable and wealthy Arab market. Saydanah will be builtupon Amphion's experience and expertise in the field of nutrigenomics, a sciencethat identifies foods that alter gene expression for better health, through itsPartner Company, WellGen. Suvani, which has previously been incorporated by Amphion, is currentlyproviding skilled software and technology support services from India to AmphionPartner Companies, Motif and FireStar. Under the Heads of Agreement, Suvaniwill be merged with a Gulf-based radio frequency identification company (RFID),to be developed by MSA, with the aim of servicing a growing Gulf RFID market.It is expected that the new company will acquire an exclusive right todistribute the products in the Gulf of Amphion's Partner Company, Axcess, aleading RFID company. The Gulf partners have committed to provide an additional US$3.5 million to fundthe further development of MSA and its companies upon their formation. Amphionwill also transfer 500,000 shares in Motif to MSA in return for a 50% interestin the new Company. Following its initial capitalization, MSA will have anestimated enterprise value of $10 million. MSA is expected to be formed no later than 1 March 2007. In the event that MSAis not formed, then MSA shall invest the US$1 million by way of subscribing for166,667 shares in Motif, and investing US$500,000 in the Gulf-based companies tobe formed by Amphion in the future. Richard C.E. Morgan Amphion's Chief Executive Officer states: "The last several years have seen dramatic economic development in the Gulf,which has been matched by rapid growth in the region's capital markets. Whilethe region is relatively rich in capital and in talented people, there is littleexperience of building companies based on cutting edge technology. WithAmphion's 20 year history and track record of investment and close relationshipsin the Gulf region, we look forward to bringing our core strategy of buildingstrong companies with solid intellectual property to the Gulf." For further information please contact: Amphion Innovations plcJosh Berkman, Media Relations +1 (646) 747 7158 Financial Dynamics +44 207 269 7169John Gilbert About Amphion Innovations plc Amphion Innovations plc is listed on the AIM Exchange in London under the symbolAMP. Amphion's business is the formation, financing, management and developmentof life sciences and technology companies, primarily in the US and UK, workingin partnership with corporations, governments, universities and entrepreneursseeking to commercialize their intellectual property. Amphion's management teamhas built more than 30 companies in 20 years, all of which have achieved valuein excess of $120 million. On the web: www.amphionplc.com About Motif BioSciences, Inc. Motif BioSciences is a population genetics company focused on discovering genescausing common diseases by utilising human genetic data from the Persian/ArabianGulf region. Motif is headquartered in the US and London, with additionaloperations in the Gulf region to develop epidemiological, genealogical andgenetic information. On the web: www.motifbio.com About WellGen, Inc. WellGen, Inc., based in New Brunswick, NJ, is a biotechnology company that isdiscovering and developing products for food, therapeutics, and dietarysupplement markets. WellGen's technical platform is a method of screening theeffect of food and related substances on the expression of genes associated withhuman health conditions. The company has developed proprietary substances thathelp reduce risk and severity for a variety of diseases. On the web: www.wellgen.com About AXCESS International Inc. AXCESS International Inc. (OTCBB:AXSI), headquartered in greater Dallas, TX,provides Enterprise DotTM, Dual-ActiveTM RFID (radio frequency identification)and Real Time Location Systems (RTLS) for asset management, physical security,sensing and supply chain efficiencies. The battery-powered (active) RFID tagslocate, identify, track, monitor, count, and protect people, assets, inventory,and vehicles. The patented technology enables applications including: automatic"hands-free" personnel access control, automatic vehicle access control andlogistics management, automatic asset management, and sensor management. AXCESSis a portfolio company of Amphion Innovations plc. On the web: www.axcessinc.com About FireStar Software, Inc. FireStar is the provider of EdgeNode, the leading InterEnterprise Service Bussoftware product for building software applications that automate the exchangeof business transactions between companies that are business partners - buyers,sellers, suppliers, vendors, manufacturers, and distributors. FireStar'sEdgeNode expands the market for these InterEnterprise Transaction Applicationsby directly addressing key obstacles to broader adoption at a significantlylower price point than alternative approaches. On the web: www.firestarsoftware.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Dec 20191:15 pmRNSAmphion Innovations
31st Dec 201912:36 pmRNSCancellation of trading on AIM
20th Nov 20197:00 amRNSDirectors' Dealings and Business Update
18th Oct 20197:00 amRNSSettlement of loan facility
11th Oct 20197:01 amRNSPolarean notes statement from Amphion Innovations
11th Oct 20197:00 amRNSSale of Partner Company Shares
3rd Oct 20197:00 amRNSSale of Partner Company Shares
25th Sep 20197:00 amRNSAmended Terms on Loan Facility
10th Sep 20194:56 pmRNSSale of Partner Company Shares
9th Aug 20194:14 pmRNSStatement on Amphion Innovations
9th Aug 20194:14 pmRNSDirectorate Change
9th Aug 20193:51 pmRNSSale of Partner Company Shares
1st Jul 20197:30 amRNSSuspension - Amphion Innovations Plc
27th Jun 20193:00 pmRNSAnnual Report and Accounts Update
14th Jun 20199:04 amRNSHolding(s) in Company
12th Jun 20197:00 amRNSLoan facility update
31st May 201910:28 amRNSHolding(s) in Company
20th May 20196:14 pmRNSHolding(s) in Company
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
1st Apr 20197:00 amRNSUpdate on Loan Facility
20th Mar 20197:00 amRNSHolding(s) in Company
19th Mar 20192:33 pmRNSSale of Partner Company Shares
18th Mar 20192:00 pmRNSPrice Monitoring Extension
15th Mar 20197:01 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSSale of Partner Company Shares
11th Mar 20194:41 pmRNSAmended Terms on Loan Facility
26th Feb 20197:00 amRNSConvertible Promissory Note Extended
14th Feb 20198:00 amRNSStatement re. Motif Bio plc
7th Feb 20199:40 amRNSStmnt re Share Price Movement
1st Feb 20197:00 amRNSAppointment of Joint Broker
21st Jan 20197:00 amRNSWellGen Finalises License Agreement
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
16th Oct 20187:00 amRNSExtended Repayment and Draw Down on Loan Facility
28th Sep 20187:00 amRNSHalf-year Report
5th Sep 20187:00 amRNSBoard Change
23rd Aug 20183:20 pmRNSPolarean update
21st Aug 20187:15 amRNSMotif Bio notes statement from Amphion Innovations
21st Aug 20187:00 amRNSSale of Partner Company Shares
1st Aug 20184:47 pmRNSResult of AGM
29th Jun 20187:00 amRNSDirectorate Change
26th Jun 20187:00 amRNSFinal Results
23rd May 20187:00 amRNSMotif Bio notes statement from Amphion Innovations
23rd May 20187:00 amRNSSale of Partner Company Shares
20th Apr 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO
26th Mar 20187:31 amRNSUpdate on Polarean Imaging proposed AIM IPO
2nd Mar 20187:00 amRNSConvertible promissory note extended to December
10th Jan 20185:09 pmRNSDirector dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.